Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-02

Clinical Trial Update: Presepsin to Safely Reduce Antibiotics in Preterm Infants [NA]

View source ↗

Summary

The study evaluates using presepsin to guide antibiotic use in preterm infants with suspected early-onset neonatal sepsis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Presepsin (presepsin)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Early-Onset Neonatal Sepsis | NA | Status: RECRUITING